Although there was no quantifiable change in tumor size after 2–3 weeks of metformin treatment, analysis of the tumor-derived biopsies revealed decreased insulin levels and a decrease in Ki67 staining, a marker of proliferation, indicating possible biological effects on tumor tissues8. The gene discussed is INS; the disease is neoplasm.